Contact this trialFirst, we need to learn more about you.
Radioisotope Therapy
FPI-2265 for Metastatic Prostate Cancer
Recruiting1 awardPhase 2 & 3
Irvine, California
This trial is testing a new drug called FPI-2265 in patients with prostate cancer that has spread to other parts of the body. They are trying to find the best dose of the drug that
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service